EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 68 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $365 | +87.2% | 45,659 | +103.4% | 0.00% | – |
| Q2 2023 | $195 | +137.8% | 22,451 | -19.7% | 0.00% | – |
| Q1 2023 | $82 | +228.0% | 27,974 | +299.3% | 0.00% | – |
| Q4 2022 | $25 | -99.7% | 7,005 | +533.4% | 0.00% | – |
| Q3 2022 | $9,000 | -10.0% | 1,106 | -15.5% | 0.00% | – |
| Q2 2022 | $10,000 | -79.6% | 1,309 | -67.6% | 0.00% | – |
| Q1 2022 | $49,000 | – | 4,046 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |